2023-10-10T10:14:12-05:00 2022-12-31 520982413 GROSS MENDELSOHN & ASSOCIATES PA 1801 PORTER STREET SUITE 500 BALTIMORE MD 21230 990 2022-01-01 954132414 CURESEARCH FOR CHILDREN'S CANCER CURE 2402352200 4800 HAMPDEN LANE PMB 183 200 BETHESDA MD 20814 KAY KOEHLER CEO 2402352200 2023-10-10 1 KAY KOEHLER 999009999 0 JENNIFER ROCK P01083312 4106855512 2023-10-04 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z KAY KOEHLER 4800 HAMPDEN LANE PMB 183 200 BETHESDA MD 20814 6306532 0 X WWW.CURESEARCH.ORG X 1987 CA CURESEARCH FUNDS AND SUPPORTS CHIDLREN'S CANCER RESEARCH AND PROVIDES EDUCATION AND RESOURCES TO ALL THOSE AFFECTED BY CHILDREN'S CANCER. 19 19 26 646 0 0 3394705 1685069 0 0 400190 86253 2450335 2618648 6245230 4389970 2146975 2295381 0 0 1904555 2040232 0 0 873336 740907 806186 4792437 5141799 1452793 -751829 8075617 6578675 441681 365058 7633936 6213617 X CURESEARCH'S MISSION IS TO FUND AND SUPPORT TARGETED AND INNOVATIVE CANCER RESEARCH WITH MEASURABLE RESULTS, AND TO BE THE AUTHORITATIVE SOURCE OF INFORMATION AND RESOURCES FOR ALL THOSE AFFECTED BY CHILDREN'S CANCER.(SEE SCHEDULE O FOR CONTINUATION)CURESEARCH SUPPORTS CHILDHOOD CANCER RESEARCH AT ALL STAGES ALONG THE RESEARCH CONTINUUM, FROM FELLOWSHIPS THAT ACCELERATE THE CAREERS OF YOUNG RESEARCHERS TO MULTI-MILLION DOLLAR GRANTS THAT SUPPORT RESEARCH TEAMS DEVELOPING POTENTIAL NEW TREATMENTS, TO CLINICAL TRIAL AWARDS THAT ENABLE HOSPITALS TO ENROLL CHILDREN BEING TREATED TODAY. IT PROVIDES EDUCATIONAL RESOURCES TO PARENTS AND CAREGIVERS, INCLUDING PLAIN LANGUAGE INFORMATION ON DIAGNOSIS AND TREATMENT, PROCEDURAL VIDEOS, AND PARENT WEBINARS. CURESEARCH ALSO RAISES FUNDS THROUGH INDIVIDUALS, CORPORATIONS, PRIVATE FOUNDATIONS, AND SPECIAL EVENTS. 0 0 3649103 2295381 CURESEARCH SUPPORTS RESEARCH EFFORTS TO IMPROVE TREATMENTS AND FIND CURES FOR CHILDREN'S CANCER. CURESEARCH SUPPORTS AN ARRAY OF PROJECTS ADDRESSING ARES OF HIGH UNMET NEED IN CHILDHOOD CANCER TREATMENT. CURESEARCH FUNDS RESEARCH AT ALL STAGES OF THE PIPELINE, INCLUDING BASIC SCIENCE, TRANSLATIONAL RESEARCH, CLINICAL TRIAL DEVELOPMENT, AND THE TESTING OF NEW CANCER THERAPIES. THIS RESEARCH IMPACTS OVER 15,000 CHILDREN DIAGNOSED WITH CANCER EACH YEAR WITH THE LONG-TERM GOAL OF DEVELOPING THERAPIES THAT CURE CHILDREN TODAY WITHOUT HARMING THEM TOMORROW. (SEE SCHEDULE O FOR CONTINUATION)CURESEARCH FUNDS CLINICAL TRIALS ACROSS THE WORLD. CLINICAL TRIALS ENSURE THAT CHILDREN WITH CANCER GET ACCESS TO THE BEST CURRENT TREATMENTS. THE DATA COLLECTED FROM CLINICAL TRIALS ENABLES RESEARCHERS TO ACHIEVE A BETTER UNDERSTANDING OF CANCER BIOLOGY AND GUIDES THE DEVELOPMENT OF NEW TREATMENTS AND TREATMENT PROTOCOLS. CLINICAL TRIALS ARE COSTLY FOR HOSPITALS, WHICH RELY ON SUPPORT FROM CURESEARCH AND OTHER ORGANIZATIONS TO BE ABLE TO PROVIDE TREATMENT FOR CHILDREN WITH CANCER. OVER THE LAST DECADE, OVER 36,000 PEDIATRIC CLINICAL TRAILS WERE CONDUCTED. IN ADDITION TO FUNDING RESEARCH, CURESEARCH ALSO PROVIDES INFORMATION AND RESOURCES TO PATIENTS AND FAMILIES. CURESEARCH RESOURCES INCLUDE CURESEARCH.ORG, A PUBLIC, DIGITAL COLLECTION OF PLAIN LANGUAGE INFORMATION ON DIAGNOSIS AND TREATMENT FOR CHILDREN'S CANCER; ; UP TO DATE CHILDHOOD CANCER STATISTICS; A LIBRARY OF PROCEDURE VIDEOS THAT DEMONSTRATE CANCER TREATMENTS FOR CHILDREN; WEBINARS AND GUIDES FOR PARENTS ON COPING WITH CHILDREN'S CANCER, FINDING COMMUNITY SUPPORT, AND REINTEGRATING A CHILD INTO SCHOOL AND SOCIAL ENVIRONMENTS; AND IMPORTANT UPDATES RELATED TO MEDICINES, DRUG APPROVALS AND OTHER CHILDREN'S CANCER RESEARCH NEWS. THE CURESEARCH WEBSITE REACHES MORE THAN 120,000 INDIVIDUALS EACH YEAR. 3649103 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 20 0 1 26 1 0 0 0 0 0 0 0 0 0 0 X 19 19 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT FL GA IL KS KY ME MD MA MI MN MS NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X X MANAGEMENT 2402352200 4800 HAMPDEN LANE PMB 183 SUITE 200 BETHESDA MD 20814 KAY KOEHLER PRESIDENT & CEO 40.00 X 364921 0 27093 TAHIRA WEST VP FINANCE & OPERATIONS 40.00 X 134720 0 5754 TIFFANI COPELAND CHIEF DEVELOPMENT OFFICER 40.00 X 196032 0 10496 JARED D BRANCAZIO CHAIR 1.00 X X 0 0 0 MICHAEL R MILLER ESQUIRE SECRETARY 1.00 X X 0 0 0 TRENT DEMULLING TREASURER 1.00 X X 0 0 0 HANK ADAMS DIRECTOR 1.00 X 0 0 0 SAMUEL BLACKMAN MD PHD DIRECTOR 1.00 X 0 0 0 CASON CARTER DIRECTOR 1.00 X 0 0 0 SHARI COLLIER DIRECTOR 1.00 X 0 0 0 SUZANNE FINNEGAN DIRECTOR 1.00 X 0 0 0 ANNIE GOULD DIRECTOR 1.00 X 0 0 0 DAVID KUPIEC DIRECTOR 1.00 X 0 0 0 JEFFREY SKOLNIK DIRECTOR 1.00 X 0 0 0 TINA SWALLOW DIRECTOR 1.00 X 0 0 0 MA CHERRY TRIVEDI DIRECTOR 1.00 X 0 0 0 KATHY WANNER DIRECTOR 1.00 X 0 0 0 BRENDA WEIGEL DIRECTOR 1.00 X 0 0 0 DAVID WHAN DIRECTOR 1.00 X 0 0 0 MIKE CARTER EMERITUS DIRECTOR 1.00 X 0 0 0 PAULA CARTER EMERITUS DIRECTOR 1.00 X 0 0 0 STUART E SIEGEL MD EMERITUS CHAIR 1.00 X 0 0 0 695673 0 43343 3 0 1 0 0 1685069 13363 1685069 100668 100668 1758941 1773356 -14415 -14415 -14415 2761194 143206 2617988 2617988 MISCELLANEOUS REVENUE 541700 660 660 660 4389970 0 0 2704901 2220381 2220381 75000 75000 739016 512900 144557 81559 1088775 464362 178074 446339 12640 4067 3408 5165 73829 32896 12526 28407 125972 66743 22280 36949 48000 48000 52145 52145 20674 20674 50701 26863 8967 14871 55868 30918 13493 11457 144175 37943 18550 87682 158841 84158 28093 46590 14831 7858 2623 4350 91683 10175 14276 67232 75126 47387 27739 51814 27452 9164 15198 SPECIAL EVENTS 27537 27537 REGISTRATIONS, PERMITS 14502 14502 MISCELLANEOUS 289 289 5141799 3649103 619360 873336 1696856 1857727 425628 166103 832045 310111 56921 47326 5050992 4184006 13175 13402 8075617 6578675 209900 193246 231781 171812 441681 365058 X 2887229 1326287 4746707 4887330 7633936 6213617 8075617 6578675 -751829 -668490 0 X X 0 1 X 1 0 X 1870428 2749767 2997810 3394705 1685069 12697779 1870428 2749767 2997810 3394705 1685069 12697779 3732305 8965474 107185 117039 92534 88403 100668 505829 791 6107 11262 41401 660 60221 13263829 11400176 0.67590 0.69090 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS - 2018 AMOUNT: $ 791. 2019 AMOUNT: $ 6,107. 2020 AMOUNT: $ 11,262. 2021 AMOUNT: $ 41,401. 2022 AMOUNT: $ 660. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2646370 -405763 100000 2140607 2448109 298261 100000 2646370 2206331 341778 100000 2448109 1938383 367948 100000 2206331 2152233 -113850 100000 1938383 0.70074 0.29926 0 0 0 X 3852686 -668490 151880 -516610 4369296 20674 20674 4389970 5273005 151880 151880 5121125 20674 20674 5141799 PART V, LINE 4: DONOR RESTRICTED ENDOWMENT FUND HAS BEEN ESTABLISHED TO ADVANCE PEDIATRIC CANCER RESEARCH BY DISEASE, BY MEDICAL DISCIPLINE, OR THROUGH RESEARCH FELLOWSHIPS. PART X, LINE 2: IN ACCORDANCE WITH FIN 48 (ASC 740), INCOME TAXES, MANAGEMENT EVALUATED ITS ACTIVITIES AND DETERMINED THAT CURESEARCH HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO OR DISCLOSURE IN THE FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF THE ACCOUNTING STANDARD. IN GENERAL, THE ORGANIZATION'S FEDERAL EXEMPT ORGANIZATION TAX RETURNS ARE SUBJECT TO EXAMINATION BY THE IRS, GENERALLY FOR A PERIOD OF THREE YEARS AFTER THE RETURNS ARE FILED. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION RESEARCH GRANTS 75000 0 0 0 0 0 0 75000 0 75000 EUROPE (INCLUDING ICELAND & GREENLAND) THERAPEUTIC 75000 AUTHORIZED CHECK 0 1 0 0 0 0 0 0 PART I, LINE 2: CURESEARCH'S MANAGEMENT WILL REQUEST PERIODIC REPORTS AND STATUS UPDATES OF ITS GRANT AWARDS THROUGHOUT THE YEAR. PART III ACCOUNTING METHOD: WALK/RUN EVENT 2761194 2761194 12000 112552 5710 12944 2761194 2761194 12000 112552 5710 12944 143206 2617988 1 MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 100656007 131924236 501 (C) (3) 37500 0 THERAPEUTIC UNIVERSITY OF FLORIDA PO BOX 113201 GAINESVILLE FL 326113201 596002052 501 (C) (3) 625000 0 THERAPEUTIC UNIVERSITY COLORADO 1800 GRANT STREET SUITE 400 DENVER CO 80203 846000555 501 (C) (3) 88900 0 THERAPEUTIC CONNETICUT CHILDRENS MEDICAL CENTER 282 WASHINGTON STREET HARTFORD CT 06106 222619869 501 (C) (3) 75000 0 THERAPEUTIC JOHNS HOPKINS 3910 KESWICK ROAD N4327B BALTIMORE MD 21211 520595110 501 (C) (3) 37500 0 THERAPEUTIC AUGUSTA UNIVERSITY MEDICAL COLLEGE OF GEORGIA 1120 15TH STREET AUGUSTA GA 30912 586002053 501 (C) (3) 100000 0 THERAPEUTIC BAYLOR COLLEGE OF MEDICINE 1 BAYLOR PLAZA HOUSTON TX 77030 741613878 501 (C) (3) 75000 0 THERAPEUTIC UNIVERSITY OF ALABAMA AT BIRMINGHAM 1720 2ND AVENUE SOUTH BIRMINGHAM AL 352940111 636005396 501 (C) (3) 500000 0 THERAPEUTIC CHILDRENS HOSPITAL OF PHILADELPHIA 2716 SOUTH STREET 15TH FLOOR PHILADELPHIA PA 191462305 231352166 501 (C) (3) 334000 0 THERAPEUTIC NATIONAL INSTITUTES OF HEALTH 900 ROCKVILLE PIKE BUILDING 31 BETHESDA MS 20892 520858115 501 (C) (3) 65000 0 THERAPEUTIC MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET BOSTON MA 021142696 042697983 501 (C) (3) 269000 0 THERAPEUTIC UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON 7000 FANNIN STREET STE 1200 HOUSTON TX 77030 741761309 501 (C) (3) 50000 0 THERAPEUTIC PART I, LINE 2: CURESEARCH'S MANAGEMENT WILL REQUEST PERIODIC REPORTS AND STATUS UPDATES OF ITS GRANT AWARDS THROUGHOUT THE YEAR. X X X X 0 0 0 0 0 0 0 0 0 KAY KOEHLER PRESIDENT & CEO 364921 0 0 0 0 0 6100 0 20993 0 392014 0 0 0 TIFFANI COPELAND CHIEF DEVELOPMENT OFFICER 196032 0 0 0 0 0 3976 0 6520 0 206528 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 THE MEMBERSHIP OF CURESEARCH'S BOARD OF DIRECTORS INCLUDES MIKE, PAULA AND CASON CARTER (FATHER, MOTHER AND SON). MIKE AND PAUL CARSON (HUSBAND AND WIFE) ARE EMERITUS DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B THE ORGANIZATION RETAINS AN OUTSIDE CPA TO PREPARE THE IRS FORM 990. PRIOR TO FILING, THE COMPLETED RETURN IS REVIEWED IN DETAIL BY THE CEO/PRESIDENT AND PRESENTED TO THE EXECUTIVE COMMITTEE OF THE BOARD. FORM 990, PART VI, SECTION B, LINE 12C EACH YEAR, ALL DIRECTORS, OFFICERS AND KEY EMPLOYEES ARE PROVIDED WITH THE CONFLICT OF INTEREST POLICY FOR REVIEW. ALL NEW EMPLOYEES ARE REQUIRED TO READ THE CONFLICT OF INTEREST POLICY AND SIGN IT AS PART OF THEIR ORIENTATION. ALL EMPLOYEES ARE REQUIRED TO READ AND RE-SIGN THE CONFLICT INTEREST POLICY ON AN ANNUAL BASIS. THE POLICY REQUIRES THAT ANYONE WHO KNOWS OF AN ACTUAL OR PERCEIVED CONFLICT OF INTEREST MUST REPORT IT. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION OF THE CEO WAS DETERMINED BY THE BOARD OF DIRECTORS USING AVAILABLE PUBLIC INFORMATION FOR COMPENSATION LEVELS AND AN EVALUATION OF THE ORGANIZATION'S PERFORMANCE AS WELL AS THAT OF THE CEO. THIS PROCESS IS DOCUMENTED IN THE BOARD MINUTES. FORM 990, PART VI, SECTION C, LINE 19 CURESEARCH'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. CURESEARCH'S FINANCIAL STATEMENTS AND FORM 990S ARE AVAILABLE ON ITS WEBSITE - CURESEARCH.ORG 990 PART VII, LINE 2C PROCESS HAS NOT CHANGED FROM PRIOR YEAR